ClinVar Miner

Submissions for variant NM_000051.3(ATM):c.3880dup (p.Ile1294fs) (rs1057516541)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000410605 SCV000485847 likely pathogenic Ataxia-telangiectasia syndrome 2016-02-23 criteria provided, single submitter clinical testing
Ambry Genetics RCV000569268 SCV000668150 pathogenic Hereditary cancer-predisposing syndrome 2017-08-11 criteria provided, single submitter clinical testing Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)
Invitae RCV000410605 SCV000937930 pathogenic Ataxia-telangiectasia syndrome 2019-06-04 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Ile1294Asnfs*8) in the ATM gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in combination with another ATM variant in an individual affected with ataxia telangiectasia (PMID: 21778326). This variant is also known as c.3880fs in the literature. ClinVar contains an entry for this variant (Variation ID: 370505). Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.